Healthstream (HSTM) FY2019 results: revenue $254 million, up 9.7% on the year
Healthstream Inc. (HSTM) reported revenue of $254 million for fiscal 2019, the year ended 31 December 2019, up 9.7% on the year before. Net income was $16 million, down 51.1%, and diluted earnings per share $0.49. The figures are the company's own, from the 10-K it filed with the SEC on 26 February 2020.
Revenue
$254 million
+9.7% on the year
FY2012FY2019
Operating margin
5.8%
6.7% a year earlier
FY2012FY2019
Net income
$16 million
-51.1% on the year
FY2012FY2019
Diluted EPS
$0.49
-51.0% on the year
FY2012FY2019
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Revenue
254
232
215
+9.7%
Cost of revenue
104
96.0
87.2
+8.2%
Gross profit
150
136
128
+10.8%
Gross margin
59.1%
58.5%
59.4%
Research and development
29.1
25.7
24.1
+13.1%
Operating income
14.7
15.5
9.4
-5.0%
Operating margin
5.8%
6.7%
4.4%
Pre-tax income
17.9
16.6
10.1
+8.2%
Income tax
3.7
3.3
1.3
+12.3%
Effective tax rate
20.8%
20.1%
12.8%
Net income
15.8
32.2
10.0
-51.1%
Net margin
6.2%
13.9%
4.7%
Diluted EPS
$0.49
$1.00
$0.31
-51.0%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Operating cash flow
65.7
43.2
46.7
+51.8%
Capital expenditure
22.0
7.2
5.5
+207.0%
Free cash flow
43.7
36.1
41.2
+21.0%
Free cash flow margin
17.2%
15.6%
19.2%
Cash from investing
-67.5
36.6
-11.6
Cash from financing
-0.9
-30.3
0.0
Depreciation and amortisation
27.9
24.2
24.0
+15.0%
Share-based compensation
4.2
1.8
1.7
+138.8%
Buybacks
0.0
n/a
n/a
Dividends paid
0.1
32.4
n/a
-99.8%
Dividend per share
n/a
$1.00
n/a
Diluted shares, weighted
32m
32m
32m
+0.3%
Shares outstanding at period end
32m
32m
32m
+0.2%
Balance sheet
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Shareholders' equity
338
319
300
+6.0%
Debt
0.0
0.0
0.0
Operating lease liabilities
30.7
n/a
n/a
Other liabilities
121
123
111
-1.9%
Total liabilities and equity
490
442
411
+10.8%
Fixed assets
26.1
15.9
8.1
+64.3%
Goodwill
102
86.1
86.1
+18.6%
Intangible assets
60.1
59.4
68.5
+1.2%
Investments
41.3
34.5
46.4
+19.8%
Cash and equivalents
132
134
84.8
-2.1%
Receivables
27.6
38.1
36.7
-27.5%
Other assets
101
73.6
80.5
+36.8%
Total assets
490
442
411
+10.8%
10-K for the year ended 31 December 2019, filed 26 February 2020: the filing.